These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15989665

  • 1. Topiramate: current status and therapeutic potential.
    Ben-Menachem E.
    Expert Opin Investig Drugs; 1997 Aug; 6(8):1085-94. PubMed ID: 15989665
    [Abstract] [Full Text] [Related]

  • 2. Preliminary observations on topiramate in pediatric epilepsies.
    Glauser TA.
    Epilepsia; 1997 Aug; 38 Suppl 1():S37-41. PubMed ID: 9092958
    [Abstract] [Full Text] [Related]

  • 3. Topiramate. Clinical profile in epilepsy.
    Sachdeo RC.
    Clin Pharmacokinet; 1998 May; 34(5):335-46. PubMed ID: 9592618
    [Abstract] [Full Text] [Related]

  • 4. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E, Kerls SP, Hammer AE, Vuong A, Messenheimer JA.
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
    Langtry HD, Gillis JC, Davis R.
    Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy.
    Fitton A, Goa KL.
    Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554
    [Abstract] [Full Text] [Related]

  • 11. Preliminary open-label experience with topiramate in primary generalized seizures.
    Biton V.
    Epilepsia; 1997 Oct; 38 Suppl 1():S42-4. PubMed ID: 9092959
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
    Ben-Menachem E.
    Epilepsia; 1997 Oct; 38 Suppl 1():S28-30. PubMed ID: 9092955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Postmarketing experience with topiramate and cognition.
    Tatum WO, French JA, Faught E, Morris GL, Liporace J, Kanner A, Goff SL, Winters L, Fix A, PADS Investigators. Post-marketing antiepileptic drug survey.
    Epilepsia; 2001 Sep; 42(9):1134-40. PubMed ID: 11580760
    [Abstract] [Full Text] [Related]

  • 18. Topiramate use in pediatric patients.
    Glauser TA.
    Can J Neurol Sci; 1998 Aug; 25(3):S8-12. PubMed ID: 9706734
    [Abstract] [Full Text] [Related]

  • 19. Anticonvulsant efficacy of topiramate in phenytoin-resistant kindled rats.
    Reissmüller E, Ebert U, Löscher W.
    Epilepsia; 2000 Apr; 41(4):372-9. PubMed ID: 10756400
    [Abstract] [Full Text] [Related]

  • 20. Clinical effects of topiramate against secondarily generalized tonic--clonic seizures.
    Wang Y, Zhou D, Wang B, Kirchner A, Hopp P, Kerling F, Pauli E, Stefan H.
    Epilepsy Res; 2002 Apr; 49(2):121-30. PubMed ID: 12049800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.